<DOC>
	<DOC>NCT00098150</DOC>
	<brief_summary>This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.</brief_summary>
	<brief_title>Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Consenting patients who participated in the core clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Safety, atopic dermatitis, adverse event, SAE, extension</keyword>
</DOC>